Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis.
Bolon
Brad
B
Amgen, Inc., Thousand Oaks, California 91320, USA.
Shalhoub
Victoria
V
Kostenuik
Paul J
PJ
Campagnuolo
Giuseppe
G
Morony
Sean
S
Boyle
William J
WJ
Zack
Debra
D
Feige
Ulrich
U
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism; D019610:Cytoprotection; D006023:Glycoproteins / Q000627:therapeutic use*; D006801:Humans; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology
D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human